logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Laura Kay Shawver

This inventor holds 21 USPTO granted patents, plus 1 CIPO patent, primarily in Cancer Therapeutics. Top assignees: Sugen Incorporated, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 1997-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Kay Shawver. Retrieved from https://idiyas.com/inventor/laura-kay-shawver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.4

ph-index = 10

Forward Citations = 457(Granted Patents)


Company Filing History:

goldMedal17 out of 157 
 
Sugen Incorporated
 patents
silverMedal5 out of 915 
 
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
 patents
bronzeMedal3 out of 1,334 
 
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.
 patents
4. 2 out of 5 
 
Bio-Signal Corporation Ltd.
 patents
5. 2 out of 16,025 
 
University of California
 patents
6. 1 out of 618 
 
Baylor College of Medicine
 patents
7. 1 out of 299 
 
Research Development Foundation
 patents
8. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Immunotoxins
Protein Kinase Inhibitors
Indolinone Libraries
Angiogenesis
Vasculogenesis
Cell Proliferation
Lipophilic Compounds
Quinazoline Compounds
Platelet Derived Growth Factor
Heteroarylcarboxamide
Isoxazole Compounds
Combinatorial Libraries
21 patents (USPTO):Explore Patents
1. 7754211 - Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens (2010-07-13),
2. 7217737 - Method and compositions for inhibiting cell proliferative disorders (2007-05-15),
3. 7202265 - Indolinone combinatorial libraries and related products and methods for the treatment of disease (2007-04-10),
4. 6906093 - Indolinone combinatorial libraries and related products and methods for the treatment of disease (2005-06-14),
5. 6846839 - Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis (2005-01-25),
6. 6696448 - 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors (2004-02-24),
7. 6649635 - Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders (2003-11-18),
8. 6596878 - Methods and compositions for inhibiting cell proliferative disorders (2003-07-22),
9. 6335356 - Method of treating a patient by parenteral administration of a lipophilic compound (2002-01-01),
10. 6316479 - Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders (2001-11-13),
11. 6147106 - Indolinone combinatorial libraries and related products and methods for (2000-11-14),
12. 6004967 - Psoriasis treatment with quinazoline compounds (1999-12-21),
13. 5990141 - Treatment of platelet derived growth factor related disorders such as (1999-11-23),
14. 5958959 - Treatment of platelet derived growth factor related disorders such as (1999-09-28),
15. 5932602 - Treatment of platelet derived growth factor related disorders such as (1999-08-03),

Title: Laura Kay Shawver - Pioneering Inventor from San Francisco

Introduction: Laura Kay Shawver is a renowned inventor based in San Francisco, CA, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Shawver holds several patents in the biotech industry, with her most recent inventions focusing on novel cancer treatments and diagnostic tools.

Career Highlights: With a distinguished career spanning over two decades, Shawver has held key positions in various biotech companies, leading research and development efforts that have resulted in significant advancements in the fight against cancer.

Collaborations: Throughout her career, Shawver has collaborated with leading researchers, scientists, and medical professionals to bring innovative solutions to the market, solidifying her reputation as a trailblazer in the biotech community.

Conclusion: Laura Kay Shawver's relentless pursuit of innovation and her commitment to improving healthcare through cutting-edge inventions have cemented her status as a pioneering inventor in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…